Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1Phase 1 1

Status

Completed 15Unknown 5Terminated 4Not yet recruiting 3Recruiting 2Withdrawn 1

Sponsor Class

OTHER 4UNKNOWN 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 64Colorectal Neoplasms 58Rectal Neoplasms 46Stomach Neoplasms 44Neoplasm Metastasis 16Pancreatic Neoplasms 15Colonic Neoplasms 13Triple Negative Breast Neoplasms 11Neoplasms 11Esophageal Neoplasms 9Nasopharyngeal Carcinoma 8Locally Advanced Rectal Cancer 7Esophageal Squamous Cell Carcinoma 7Cholangiocarcinoma 6Biliary Tract Neoplasms 6Carcinoma, Hepatocellular 5HER2 Positive Metastatic Breast Cancer 4Colorectal Cancer Metastatic 4Adenocarcinoma 4Solid Tumor 3Recurrence 3Gallbladder Neoplasms 3Anus Neoplasms 3Advanced Breast Cancer 3Squamous Cell Carcinoma of Head and Neck 2Solid Tumors 2Neuroendocrine Tumors 2Locally Advanced Colon Cancer 2Hyperthermia 2Head and Neck Neoplasms 2

Interventions

Sorafenib 46lenvatinib 44apatinib 23sintilimab 22Fluorouracil 21camrelizumab 20Oxaliplatin 17Radiofrequency Ablation 16Radiosurgery 15Hepatectomy 15tislelizumab 14Leucovorin 14Radiotherapy 12Doxorubicin 12toripalimab 11Folfox protocol 10Bevacizumab 10Immune Checkpoint Inhibitors 9Epirubicin 9regorafenib 8Ethiodized Oil 8durvalumab 7donafenib 7anlotinib 7Neoadjuvant Therapy 7pembrolizumab 6entecavir 6Surgical Procedures, Operative 6Nivolumab 6Injections 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Hepatocellular × Capecitabine × Clear all
NCT04411706 2020-06-24

A Study of Sintilimab Combined With Apatinib and Capecitabine in Advanced Hepatocellular Carcinoma

China Three Gorges University, Yichang, China

Phase 2 Unknown
46 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03114085 2017-05-15

Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma

First Affiliated Hospital of Guangxi Medical University

Phase 2 Unknown
170 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02403544 2016-01-05

Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma

ChineseAMS

Phase 1 Unknown
30 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00561522 2010-07-21

Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection

Fudan University

Phase 2/3 Unknown
290 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Neoplasm Metastasis, Recurrence

NCT00752063 2008-09-15

SECOX

The University of Hong Kong

Phase 2 Unknown
52 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡